See more : DroneShield Limited (DRO.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Tilray Brands, Inc. (TLRY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tilray Brands, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Elanor Investors Group (ENN.AX) Income Statement Analysis – Financial Results
- Creative Global Technology Holdings Limited Ordinary Shares (CGTL) Income Statement Analysis – Financial Results
- Haydale Graphene Industries plc (HAYD.L) Income Statement Analysis – Financial Results
- Corporación Interamericana de Entretenimiento, S.A.B. de C.V. (CIEZF) Income Statement Analysis – Financial Results
- Cofinimmo SA (CFMOF) Income Statement Analysis – Financial Results
Tilray Brands, Inc. (TLRY)
About Tilray Brands, Inc.
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 788.94M | 627.12M | 628.37M | 513.09M | 391.00M | 175.25M | 28.63M | 15.17M | 6.47M | 443.70K | 0.00 | 0.00 |
| Cost of Revenue | 565.59M | 480.16M | 511.56M | 389.90M | 253.31M | 119.50M | 3.97M | 2.33M | 1.88M | 567.59K | 0.00 | 0.00 |
| Gross Profit | 223.35M | 146.96M | 116.82M | 123.18M | 137.68M | 55.74M | 24.66M | 12.84M | 4.58M | -123.89K | 0.00 | 0.00 |
| Gross Profit Ratio | 28.31% | 23.43% | 18.59% | 24.01% | 35.21% | 31.81% | 86.13% | 84.63% | 70.87% | -27.92% | 0.00% | 0.00% |
| Research & Development | 635.00K | 682.00K | 1.52M | 830.00K | 1.85M | 1.03M | 380.00K | 365.52K | 168.99K | 55.95K | 0.00 | 0.00 |
| General & Administrative | 171.56M | 165.16M | 162.80M | 111.58M | 88.30M | 70.83M | 24.64M | 5.25M | 2.21M | 5.33M | 45.34K | 98.51K |
| Selling & Marketing | 79.17M | 65.78M | 65.86M | 44.12M | 29.92M | 20.67M | 9.21M | 4.95M | 2.76M | 579.52K | 0.00 | 0.00 |
| SG&A | 250.72M | 230.94M | 228.66M | 155.69M | 118.22M | 91.50M | 33.85M | 10.20M | 4.97M | 5.91M | 45.34K | 98.51K |
| Other Expenses | 146.74M | -66.91M | 115.19M | 35.22M | 15.68M | 10.41M | 1.98M | 379.96K | 277.37K | -3.28M | 0.00 | 0.00 |
| Operating Expenses | 398.10M | 325.11M | 345.37M | 191.74M | 135.75M | 102.94M | 37.32M | 11.28M | 5.42M | 6.01M | 45.34K | 98.51K |
| Cost & Expenses | 963.69M | 805.27M | 856.93M | 581.64M | 389.07M | 222.44M | 34.24M | 13.61M | 7.30M | 5.81M | 45.34K | 98.51K |
| Interest Income | 12.83M | 33.03M | 11.74M | 2.93M | 5.79M | 10.61M | 4.93M | 827.91K | 215.83K | 104.79K | 3.35K | 2.08K |
| Interest Expense | 49.26M | 13.59M | 39.68M | 30.90M | 24.78M | 5.75M | 1.05M | 287.34K | 215.83K | 104.79K | 3.35K | 2.08K |
| Depreciation & Amortization | 126.91M | 130.15M | 115.19M | 35.22M | 15.68M | 16.95M | 5.18M | 1.44M | 730.05K | 306.47K | 0.00 | 0.00 |
| EBITDA | -72.84M | -889.52M | -246.40M | -218.36M | -18.40M | -36.66M | -658.00K | 4.37M | 115.11K | -5.06M | -1.43M | -608.47K |
| EBITDA Ratio | -9.23% | -18.32% | 42.73% | 5.90% | 17.18% | 8.19% | -2.55% | 28.80% | -1.73% | -1,141.18% | 0.00% | 0.00% |
| Operating Income | -174.75M | -1.37B | 153.30M | -4.95M | 51.48M | -2.60M | -9.64M | -1.03M | -836.23K | -2.73M | -45.34K | -98.51K |
| Operating Income Ratio | -22.15% | -218.41% | 24.40% | -0.96% | 13.17% | -1.48% | -33.66% | -6.81% | -12.93% | -615.78% | 0.00% | 0.00% |
| Total Other Income/Expenses | -74.28M | -80.50M | 169.73M | -212.82M | -5.18M | 100.79M | 40.23M | 151.61K | 221.29K | -2.53M | 0.00 | 2.08K |
| Income Before Tax | -249.02M | -1.45B | -440.67M | -344.99M | -58.19M | -11.56M | 27.81M | 3.22M | -614.94K | -5.27M | -41.99K | -96.43K |
| Income Before Tax Ratio | -31.56% | -231.24% | -70.13% | -67.24% | -14.88% | -6.60% | 97.13% | 21.20% | -9.51% | -1,186.63% | 0.00% | 0.00% |
| Income Tax Expense | -26.62M | -7.18M | -6.54M | -8.97M | 2.82M | 631.19K | 4.97M | 99.29K | -920.06K | -3.38M | 0.00 | 0.00 |
| Net Income | -244.98M | -1.44B | -434.13M | -336.01M | -61.02M | -12.19M | 22.84M | 3.12M | 305.12K | -5.27M | -41.99K | -96.43K |
| Net Income Ratio | -31.05% | -230.10% | -69.09% | -65.49% | -15.61% | -6.96% | 79.77% | 20.54% | 4.72% | -1,186.63% | 0.00% | 0.00% |
| EPS | -0.33 | -2.34 | -0.90 | -1.25 | -0.61 | -0.06 | 0.17 | 0.04 | 0.01 | -0.14 | -0.01 | -0.04 |
| EPS Diluted | -0.33 | -2.34 | -0.90 | -1.25 | -0.61 | -0.06 | 0.16 | 0.04 | 0.01 | -0.14 | -0.01 | -0.04 |
| Weighted Avg Shares Out | 742.65M | 617.98M | 481.22M | 269.55M | 100.46M | 203.46M | 134.96M | 87.45M | 48.98M | 38.04M | 3.34M | 2.31M |
| Weighted Avg Shares Out (Dil) | 742.65M | 617.98M | 481.22M | 269.55M | 100.46M | 203.46M | 139.05M | 93.39M | 48.98M | 38.04M | 3.34M | 2.31M |
Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms
Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?
Here's Why Tilray Brands, Inc. (TLRY) Fell More Than Broader Market
TLRY Grows Craft Beer Portfolio by Acquiring Molson Coors Brands
Tilray Brands Completes Acquisition of Craft Beer Brands and Breweries from Molson Coors Beverage Company
Best Canadian Cannabis Stocks to Watch in September
Cannabis stocks rally as analyst hails pot as an ‘increasingly bipartisan' issue
Tilray Brands, Inc. (TLRY) Trades Flat On The Day: What You Should Know
Here's why Tilray Brands, Canopy Growth, Curaleaf stocks have crashed
3 New Reasons to Consider Buying Tilray Brands Stock in 2024
Source: https://incomestatements.info
Category: Stock Reports